PrimeVax Immuno-Oncology Competitors and Similar CompaniesClear all

PrimeVax Immuno-Oncology's competitors and similar companies include Catapult Therapeutics, immunoSCAPE and Ossium Health.

	PrimeVax Immuno-Oncology PrimeVax Immuno-Oncology is a company that develops a multi-mechanism treatment for cancer, leveraging whole body systemic fever along with personalized neo-antigens.	Catapult Therapeutics Catapult Therapeutics is a biotech company developing CAP-100, a humanized anti-CCR7 antibody.	immunoSCAPE immunoSCAPE is a company that measures treatment and outcome-associated changes in antigen-specific T cells and patient immune response.	Ossium Health Ossium Health is a company building bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation.
Founding Date	Founding Date 2015	Founding Date 2015	Founding Date 2016	Founding Date 2016
Type	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech life sciences oncology therapy	Tags Healthcare biotech life sciences oncology therapy	Tags Healthcare biotech life sciences oncology therapy	Tags Healthcare biotech life sciences oncology therapy
Locations	Locations Orange, US HQ	Locations Lelystad, NL HQ 's Hertogenbosch, NL	Locations Singapore, SG HQ Nucleos, SG Cambridge, US San Diego, US	Locations San Francisco, US HQ Indianapolis, US
Employees	Employees 7	Employees 5	Employees 329% decrease	Employees 89
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 14m (about 5 years ago)	Latest funding round $ 63m (over 5 years ago)
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 24.9m	Total funding raised $ 73.4m